Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
12/1998
12/30/1998WO1998058925A1 Barbituric acid derivatives with antimetastatic and antitumor activity
12/30/1998WO1998058919A1 Angiogenesis inhibiting 5-substituted-1,2,4-thiadiazolyl derivatives
12/30/1998WO1998058910A1 Prostaglandin pharmaceutical compositions
12/30/1998WO1998058666A1 Use of proteolytic enzymes for treating uveitis
12/30/1998WO1998058646A1 Use of somatostatin agonists and antagonists for treating diseases related to the eye
12/30/1998EP0887346A2 Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives, their preparation and their use as alpha1A/1L adrenoceptor agonists
12/30/1998CN1203532A Method for treating photoreceptors using glial cell line-derived neurotrophic factor (gdnf) protein product
12/30/1998CN1203531A Method for treating retinal ganglion cell injury using glial cell line-derived neurotrophic factor (GDNF) protein product
12/30/1998CN1203529A 'Gamma'-RAR antagonist ligand or 'alpha'-RAR agonist ligand as apoptosis inhibitor
12/30/1998CN1203228A Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives
12/30/1998CN1203104A External-use medicine for treating myopia
12/30/1998CA2294259A1 Barbituric acid derivatives with antimetastatic and antitumor activity
12/29/1998US5853703 Preventing and reversing the formation of advanced glycosylation endproducts
12/29/1998CA1340295C Human somatomedin carrier protein subunits and process for procucing them
12/24/1998DE19726251A1 Verwendung proteolytischer Enzyme zur Behandlung von Uveitis The use of proteolytic enzymes for the treatment of uveitis
12/23/1998WO1998057966A1 Novel aryloxy substituted pyrimidine imidazole compounds
12/23/1998WO1998057954A1 Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists
12/23/1998WO1998057940A1 Heterocyclic substituted piperidines and uses thereof
12/23/1998WO1998057936A1 Quinoline derivatives as pde iv and/or tnf inhibitors
12/23/1998EP0885204A1 Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds
12/23/1998EP0885011A2 Vaccines
12/23/1998CN1202894A Substituted 4-(1H-benzimidzol-2-yl-amino) piepridines useful for the treatment of allergic diseases
12/23/1998CN1202893A Novel isoxazoline and isoxazole fibrinogen deceptor antagonists
12/23/1998CN1202886A 3-spiro-indolin-2-one derivatives, its preparing method and its medicinal compounds
12/23/1998CA2430623A1 Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives
12/23/1998CA2294549A1 Heterocyclic substituted piperidines and uses thereof
12/23/1998CA2294137A1 Novel aryloxy substituted pyrimidine imidazole compounds
12/23/1998CA2292883A1 Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists
12/23/1998CA2289100A1 Quinoline derivatives as pde iv and/or tnf inhibitors
12/22/1998US5852056 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders
12/22/1998US5852031 2,7-substituted octahydro-1H-pyrido 1,2-a!pyrazine derivatives
12/22/1998US5851999 FLK-1 is a receptor for vascular endothelial growth factor
12/22/1998US5851809 Tryptophanyl tRNA Synthetase polynucleotides of Streptococcus
12/20/1998CA2235441A1 Novel compounds
12/17/1998WO1998056783A1 Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing same
12/17/1998WO1998056377A1 Novel pyrazole and pyrazoline substituted compounds
12/17/1998CA2294057A1 Novel pyrazole and pyrazoline substituted compounds
12/16/1998EP0884316A1 Quinazoline-4-one AMPA antagonists
12/16/1998EP0884310A1 Quinazolin-4-one ampa antagonists
12/16/1998EP0703902B1 Process for the production of piperidine derivatives
12/16/1998EP0699191B1 Sulfonamides and derivatives thereof that modulate the activity of endothelin
12/16/1998CN1202152A 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency
12/16/1998CN1201671A Medicinal cream for curing myopia and weak visual acuity
12/15/1998US5849798 Polyaromatic heterocyclic compounds and pharmaceutical/cosmetic compositions comprised thereof
12/15/1998US5849792 Storage-stable prostaglandin compositions
12/15/1998US5849791 Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
12/15/1998US5849736 Isoxazoline and isoxazole fibrinogen receptor antagonists
12/15/1998US5849709 Saccharopeptides and derivatives thereof
12/15/1998US5849324 Use of indigestible oligosaccharides to reduce the incidence of otitis media in humans
12/15/1998US5849291 Opthalmic non-irritating iodine medicament
12/15/1998CA2160462C Substituted pyrrolidin-3-yl-alkyl-piperidines useful as tachykinin antagonists
12/10/1998WO1998055641A2 Somatic gene therapy to suppress secondary cataract formation
12/10/1998WO1998055606A2 Lactoferrin receptor genes of moraxella
12/10/1998WO1998055474A1 5-naphthalen-1-yl-1,3-dioxane derivatives, preparation and therapeutic application
12/10/1998WO1998055161A1 New medicaments based on polymers composed of methacrylamide-modified gelatin
12/10/1998WO1998035967A3 Biazacyclic crf antagonists
12/10/1998CA2292838A1 Lactoferrin receptor genes of moraxella
12/10/1998CA2290806A1 New medicaments based on polymers composed of methacrylamide-modified gelatin
12/10/1998CA2290695A1 5-naphthalen-1-yl-1,3-dioxane derivatives, preparation and therapeutic application
12/09/1998EP0882718A1 Benzimidazole derivatives
12/09/1998EP0882038A1 Novel substituted n-methyl-n-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases
12/09/1998EP0881909A1 Recombinant tissue plasminogen activator (rtpa) for preventing secondary cataracts following cataract operations
12/09/1998CN1201388A Pure 3R-3'R stereoisomer of zeaxanthin for treating macular degeneration in humans
12/09/1998CN1200926A Composition containing diflucortolone acetate butyrate
12/08/1998US5847004 Method for in vivo reduction of nitric oxide levels and compositions useful therefor
12/08/1998US5846988 Thiazolidine-4-carboxylic acid derivatives as cytoprotective agents
12/08/1998CA2073180C Therapeutic uses of melanin
12/08/1998CA2053209C Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists
12/03/1998WO1998054093A1 Novel angiogenesis inhibitors
12/03/1998WO1998053846A1 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
12/03/1998WO1998053821A1 USE OF 4-SUBSTITUTED TETRAHYDROPYRIDINES FOR MAKING MEDICINES ACTING ON TGF-β1
12/03/1998WO1998053809A1 Ophthalmic compositions for treating ocular hypertension
12/03/1998WO1998053806A1 Medicinal compositions for topical administration containing vitamin d and vitamin k
12/03/1998WO1998045332A3 Humanized antibodies and methods for forming humanized antibodies
12/03/1998WO1998045331A3 Anti-vegf antibodies
12/03/1998CA2291777A1 Ophthalmic compositions for treating ocular hypertension
12/03/1998CA2291709A1 Novel angiogenesis inhibitors
12/02/1998EP0881297A2 Histidine kinase
12/02/1998EP0881292A2 Streptocococcus pneumoniae peptide release factor
12/02/1998EP0880351A1 Polymeric quaternary ammonium compounds and their use as ophthalmic antimicrobials
12/02/1998EP0752875A4 Glioblastoma-derived angiogenesis inhibiting factor
12/02/1998EP0544779B1 Heterocyclic compounds and their preparation and use
12/02/1998CN1200673A Eye drops
12/02/1998CN1200672A Pharmaceutical formulation
12/02/1998CN1200374A Vitronectin receptor antagonists, their prepn. and their use
12/02/1998CN1200373A Vitronectin receptor antagonists, their prepn. and use
12/01/1998US5843994 Compositions and methods for treating and preventing pathologies including cancer
12/01/1998US5843933 11β-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agents
11/1998
11/30/1998CA2233577A1 Histidine kinase
11/29/1998CA2233561A1 Novel compounds
11/26/1998WO1998052943A1 Indoline derivatives as 5ht2c receptor antagonists
11/26/1998WO1998052906A1 New nitromethyl ketones, process for preparing them and compositions containing them
11/26/1998WO1998052612A1 Antiseptic composition
11/26/1998WO1998052602A1 Use of hyaluronidase in the manufacture of an ophthalmic preparation for liquefying vitreous humor in the treatment of eye disorders
11/26/1998WO1998052579A1 Ophthalmic compositions containing a divalent salt and a non steroidal anti-inflammatory drugs as a precipitate
11/26/1998CA2290831A1 New nitromethyl ketones, process for preparing them and compositions containing them
11/26/1998CA2290546A1 Ophthalmic compositions containing a divalent salt and a non steroidal anti-inflammatory drugs as a precipitate
11/26/1998CA2290475A1 Indoline derivatives as 5ht2c receptor antagonists
11/26/1998CA2290461A1 Antiseptic composition
11/26/1998CA2288622A1 Use of hyaluronidase in the manufacture of an ophthalmic preparation for liquefying vitreous humor in the treatment of eye disorders
1 ... 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 ... 531